E-LIB Suche - Ergebnisse für: Heyen, R.

1

Mechanistic investigations of kinase inhibitor-mediated hyp..:

Song, L. ; Hemkens, M. ; Heyen, J.R..
Journal of Pharmacological and Toxicological Methods. 85 (2017) - p. 89 , 2017

2

Interleukin-6 Facilitates Lipopolysaccharide-Induced Disrup..:

Sparkman, Nathan L. ; Buchanan, Jessica B. ; Heyen, Jonathan R. R....
The Journal of Neuroscience. 26 (2006) 42 - p. 10709-10716 , 2006

Link: https://doi.org/10.1523/..

3

#128 Mice deficient in interleukin-6 are refractory to lipo..:

Sparkman, N.L. ; Heyen, J.R. ; Burton, M.D...
Brain, Behavior, and Immunity. 19 (2005) 4 - p. e66-e67 , 2005

Link: https://doi.org/10.1016/..

4

Interleukin (IL)-10 inhibits IL-6 production in microglia b..:

Heyen, Jonathan R.R ; Ye, Shi-ming ; Finck, Brian N.
Molecular Brain Research. 77 (2000) 1 - p. 138-147 , 2000

Link: https://doi.org/10.1016/..

5

Behavior of Adult and Aged Mice Before and After Central In..:

Nelson, Kathryn P ; Marks, Natalie L ; Heyen, Jonathan R.R.
Physiology & Behavior. 66 (1999) 4 - p. 673-679 , 1999

Link: https://doi.org/10.1016/..

6

PRISMA — Ein Informationssystem für Moderne Kunst im Intern..:

, In: Informatik '97 Informatik als Innovationsmotor; Informatik aktuell,

Dupont-Christ, S. ; Göttler, H. ; Heyen, R.... - p. 297-306 , 1997

Link: https://doi.org/10.1007/..

7

Validation and utility of the PhysioTel™ Digital M11 teleme..:

Cordes, Jason S. ; Heyen, Jonathan R. ; Volberg, Marlo L....
Journal of Pharmacological and Toxicological Methods. 79 (2016) - p. 72-79 , 2016

Link: https://doi.org/10.1016/..

8

Technological Advances in Cardiovascular Safety Assessment ..:

Berridge, Brian R. ; Schultze, A. Eric ; Heyen, Jon R...
ILAR Journal. 57 (2016) 2 - p. 120-132 , 2016

Link: https://doi.org/10.1093/..

9

Contributors:

, In: The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment,

Barrow, Paul ; Bayne, Kathryn ; Bluemel, Joerg... - p. xiii-xv , 2015

Link: https://doi.org/10.1016/..

10

The Use of Nonhuman Primates in Cardiovascular Safety Asses..:

, In: The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment,

Heyen, Jonathan R. ; Vargas, Hugo M. - p. 551-578 , 2015

Link: https://doi.org/10.1016/..

11

Health and environmental sciences institute integrated stra..:

Engwall, Michael J. ; Walisser, Jacqueline A. ; Saul, Jim...
Journal of Pharmacological and Toxicological Methods. 70 (2014) 3 - p. 336 , 2014

Link: https://doi.org/10.1016/..

12

Characterization, Biomarkers, and Reversibility of a Monocl..:

Heyen, Jonathan R. ; Rojko, Jennifer ; Evans, Mark...
Toxicologic Pathology. 42 (2014) 4 - p. 765-773 , 2014

Link: https://doi.org/10.1177/..

13

Cardiovascular differentiation of imatinib and bosutinib in..:

Heyen, Jonathan R. ; Hu, Wenyue ; Jamieson, Joseph...
International Journal of Hematology. 98 (2013) 5 - p. 597-607 , 2013

Link: https://doi.org/10.1007/..

14

Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, S..:

Yanochko, Gina M. ; Vitsky, Allison ; Heyen, Jonathan R....
Toxicological Sciences. 135 (2013) 2 - p. 451-464 , 2013

Link: https://doi.org/10.1093/..

15

Mechanistic Investigation of Imatinib-Induced Cardiac Toxic..:

Hu, Wenyue ; Lu, Shuyan ; McAlpine, Indrawan...
Toxicological Sciences. 129 (2012) 1 - p. 188-199 , 2012

Link: https://doi.org/10.1093/..